Oncological outcomes of salvage radical prostatectomy for recurrent prostate cancer in the contemporary era: A multicenter retrospective study

Urologic Oncology: Seminars and Original Investigations - Tập 39 - Trang 296.e21-296.e29 - 2021
Giancarlo Marra1,2, Robert Jeffrey Karnes3, Giorgio Calleris1, Marco Oderda1, Paolo Alessio1, Anna Palazzetti1, Antonino Battaglia1,4, Francesca Pisano1,5, Stefania Munegato1, Fernando Munoz6, Claudia Filippini7, Umberto Ricardi8, Estefania Linares2, Rafael Sanchez-Salas2, Sanchia Goonewardene9, Prokar Dasgupta9, Ben Challacombe9, Rick Popert9, Declan Cahill10, David Gillatt11
1Department of Urology, San Giovanni Battista Hospital, Città della Salute e della Scienza, University of Turin, Turin, Italy
2Department of Urology, Institut Mutualiste Montsouris, Paris, France
3Department of Urology, Mayo Clinic, Rochester, MN
4Department of Urology, Leuven University Hospitals, Leuven, Belgium
5Department of Urology, Fundaciò Puigvert, Barcelona, Spain
6Department of Radiotherapy, Pasini Hospital, Aosta, Italy
7Department of Statistics, University of Turin, Turin, Italy
8Department of Radiotherapy and School of Medicine Chair, University of Turin, Turin, Italy
9Department of Urology, Urology Centre, Guy's Hospital, London, UK
10Department of Urology, Royal Marsden Hospital, London, UK
11Department of Urology, Bristol NHS Foundation Trust, Bristol, UK

Tài liệu tham khảo

Cooperberg, 2010, Time trends and local variation in primary treatment of localized prostate cancer, J Clin Oncol, 28, 1117, 10.1200/JCO.2009.26.0133

Bolla, 2010, External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study, Lancet Oncol, 11, 1066, 10.1016/S1470-2045(10)70223-0

Stabile, 2019, Medium-term oncological outcomes in a large cohort of men treated with either focal or hemi-ablation using high-intensity focused ultrasonography for primary localized prostate cancer, BJU Int, 124, 431, 10.1111/bju.14710

Zapatero, 2009, Post-treatment prostate biopsies in the era of three-dimensional conformal radiotherapy: what can they teach us?, Eur Urol, 55, 902, 10.1016/j.eururo.2008.04.076

Marra, 2018, Focal therapy in localised prostate cancer: real-world urological perspective explored in a cross-sectional European survey, Urol Oncol Semin Orig Investig, 36

Cooperberg, 2010, Time trends and local variation in primary treatment of localized prostate cancer, J Clin Oncol, 28, 1117, 10.1200/JCO.2009.26.0133

Zargar, 2017, Salvage robotic prostatectomy for radio recurrent prostate cancer: technical challenges and outcome analysis, Minerva Urol e Nefrol, 69, 26

Bates, 2015, Salvage robot assisted radical prostatectomy: a propensity matched study of perioperative, oncological and functional outcomes, Eur J Surg Oncol, 41, 1540, 10.1016/j.ejso.2015.06.002

Marra, 2019, Complications, oncological and functional outcomes of salvage treatment options following focal therapy for localized prostate cancer: a systematic review and a comprehensive narrative review, World J Urol, 10.1007/s00345-019-02642-9

Chade, 2011, Salvage radical prostatectomy for radiation-recurrent prostate cancer: a multi-institutional collaboration, Eur Urol, 60, 205, 10.1016/j.eururo.2011.03.011

Chade, 2012, Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: a systematic review of the literature, Eur Urol, 61, 961, 10.1016/j.eururo.2012.01.022

Calleris, 2019, Is it worth to perform salvage radical prostatectomy for radio-recurrent prostate cancer? A literature review, World J Urol, 10.1007/s00345-019-02749-z

Gontero, 2019, Salvage radical prostatectomy for recurrent prostate cancer: morbidity and functional outcomes from a large multicenter series of open versus robotic approaches, J Urol, 202, 725, 10.1097/JU.0000000000000327

Marra, 2020, Outcomes of salvage radical prostatectomy for M0 castration-resistant recurrent prostate cancer: a reasonable option in the era of new antiandrogen therapies?, Eur Urol Focus

Marra, 2019, Salvage local treatments after focal therapy for prostate cancer, Eur Urol Oncol, 2, 526, 10.1016/j.euo.2019.03.008

Mitropoulos, 2012, Reporting and grading of complications after urologic surgical procedures: an ad hoc EAU guidelines panel assessment and recommendations, Eur Urol, 61, 341, 10.1016/j.eururo.2011.10.033

Thompson, 2019, Pathological findings and magnetic resonance imaging concordance at salvage radical prostatectomy for local recurrence following partial ablation using high intensity focused ultrasound, J Urol, 201, 1134, 10.1097/JU.0000000000000135

Novara G, Ficarra V, Mocellin S, Ahlering TE, Carroll PR, Graefen M, et al. Platinum priority-review-prostate cancer systematic review and meta-analysis of studies reporting oncologic outcome after robot-assisted radical prostatectomy n.d. https://doi.org/10.1016/j.eururo.2012.05.047

Payne H, Khan, A, Chowdhury, S, Davda, R. Hormone therapy for radiorecurrent prostate cancer n.d. doi:10.1007/s00345-012-0952-8.

Xie, 2017, Metastasis-free survival is a strong surrogate of overall survival in localized prostate cancer, J Clin Oncol, 35, 3097, 10.1200/JCO.2017.73.9987

Preisser, 2019, Impact of positive surgical margin length and Gleason grade at the margin on biochemical recurrence in patients with organ-confined prostate cancer, Prostate, 10.1002/pros.23908

Mahal, 2016, Association of very low prostate-specific antigen levels with increased cancer-specific death in men with high-grade prostate cancer, Cancer, 122, 78, 10.1002/cncr.29691

Kim, 2013, Defining the optimal approach to the patient with postradiation prostate-specific antigen recurrence using outcome data from a prospective randomized trial, Cancer, 119, 3280, 10.1002/cncr.28202

Tilki, 2019, External validation of the European Association of Urology biochemical recurrence risk groups to predict metastasis and mortality after radical prostatectomy in a European cohort, Eur Urol, 75, 896, 10.1016/j.eururo.2019.03.016

Leow, 2016, Robot-assisted versus open radical prostatectomy: a contemporary analysis of an all-payer discharge database, Eur Urol, 70, 837, 10.1016/j.eururo.2016.01.044

Pooli A, Salmasi A, Johnson DC, Lenis AT, Faiena I, Lebacle C, et al. Clinical-prostate cancer positive surgical margins at radical prostatectomy in the United States: institutional variations and predictive factors 2019. https://doi.org/10.1016/j.urolonc.2019.08.016

Thông tin
Thông tin xuất bản

Urologic Oncology: Seminars and Original Investigations

Tập 39

296.e21-296.e29

Thông tin tác giả